Nevimune Tablet, containing 200mg of Nevirapine, is an essential antiretroviral medication used in the treatment and prevention of HIV-1 infection in adults and pediatric patients. It is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that functions by inhibiting the HIV-1 reverse transcriptase, thus preventing the viral replication and multiplication. Nevimune Tablet should be administered with other antiretroviral agents as part of a combination therapy, as recommended by the current guidelines for the management of HIV-1 infection. The medication should be taken orally, with or without food, and the dosage may vary based on the patient's weight and the severity of the condition. It is crucial to adhere to a regular dosing schedule to ensure effective viral load suppression and improved clinical outcomes. Nevimune Tablet should be used with caution in patients with liver or kidney dysfunction and in patients coinfected with tuberculosis. Regular monitoring of liver function tests, viral load, and CD4+ cell count is recommended during treatment.